Treatment of Glycogen Storage Disease Type I in Iron Deficiency Anemia

Clinical Scenario

Iron Deficiency Anemia

This protocol addresses the management of Glycogen storage disease type I when iron deficiency anemia has been documented as a concurrent condition. Recognising this comorbidity alters the therapeutic approach and requires specific consideration alongside overall metabolic management.

Approach — partial overview

When iron deficiency anemia is confirmed in this setting, iron supplementation is a recommended component of the management plan, integrated with optimisation of metabolic control. The full protocol specifies how route selection and response considerations are determined in this clinical context.

The complete structured regimen — including route guidance, sequencing, and monitoring — is available in the full protocol below.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1038/gim.2014.128

If iron deficiency anemia is documented, iron supplementation (oral or i.v.) as needed and optimization of metabolic control are recommended.
Intravenous iron infusions can partially overcome the resistance to iron therapy, but, because of an inhibition of macrophage recycling of iron, a good response is typically not seen.

View source ↗